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Background: Most tendon pathology is associated with degeneration, which is thought to involve cyclic loading
and cumulative age-related changes in tissue architecture. However, the association between aging and
degeneration of the extracellular matrix (ECM) in tendons has not been investigated extensively.
Methods: We examined tenocytes from Achilles tendons taken from rats of three different ages (2, 12, and
24 months). Tenocyte viability was assessed using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) assay. Quantitative real-time polymerase chain reaction (PCR) was used to determine the levels of mRNAs
that encode type-I collagen, matrix metalloproteinase (MMP)-2 and −9, tissue inhibitor of metalloproteinase (TIMP)-1
and −2 and transforming growth factor (TGF)-β1. Gelatin zymography was used to evaluate the enzymatic activities
of MMP-2 and −9. Furthermore, the concentration of TGF-β1 in conditioned medium was evaluated using
enzyme-linked immunosorbent assay (ELISA).
Results: The results of the MTT assay showed that the number of viable tenocytes decreased with age. No
differences were observed in the levels of mRNAs that encode type-I collagen and TGF-β1 among the three age
groups, and the TGF-β1 concentration did not change with age. However, mRNAs that encode MMP-2 and −9
were significantly more abundant in tenocytes from the aging group, and gelatin zymography revealed that the
enzymatic activities of MMP-2 and −9 also increased significantly with age. Furthermore, as compared with young
group, mRNAs that encode TIMP-1 and −2 were significantly decreased in tenocytes from the aging group.
Conclusions: Activities of MMP-2 and MMP-9 in tenocytes increase with age. This might provide a mechanistic
explanation of how aging contributes to tendinopathy or tendon rupture with age.
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Age is commonly associated with increased prevalence of
tendinosis and injury [1-3], and degenerative changes are
commonly found in the tendons of people over 35 years of
age [4]. The most common pathology observed during sur-
gery for chronic painful Achilles tendon is degeneration or
tendinosis [2]. In addition, most pathological changes in
spontaneously ruptured tendons are degenerative [4].
Little is known about the roles of mechanisms respon-
sible for aging in the degeneration of tendons, but* Correspondence: tsaiwc@adm.cgmh.org.tw
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reproduction in any medium, provided the orbiophysical investigations have implicated a role for
imbalanced homeostatic turnover of the extracellular
matrix (ECM) of the tendon [5-7]. Accumulated physical
damage on the rotator cuff increased cleavage of matrix
components in aging tendons [8]. It appears that both
insufficient synthesis and increased degradation of ECM
might contribute to the mechanical deterioration of
tendons.
The degree of ECM breakdown is controlled by the
release of matrix metalloproteinases (MMPs) and their
inhibition by tissue inhibitor of metalloproteinases
(TIMPs) [9]. Several MMPs have been implicated in
chronic tendon pathologies, with increased levels of ex-
pression of MMP-1, MMP-2, MMP-9, MMP-19, MMP-
23 and MMP-25, and decreased levels of expression ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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either ruptured or painful tendons [5-8,10]. However,
there is currently no direct evidence of an association
between age and the activities of MMPs. Gelatinases
(MMP-2 and −9) cleave soluble type-IV collagen [11], as
well as both native and reconstituted type-I collagen
[12]. Cyclic strain may increase the levels of both MMP-
2 and MMP-9 in horse superficial digital flexor tendons
and human Achilles tendons [5]. Moreover, aging en-
hances this mechanically induced MMP activity [13].
Therefore, it is crucial to investigate whether aging
affects the enzymatic activities of MMP-2 and −9 and
their physiologic inhibitors, TIMP-2 and −1 directly, as
this could ultimately improve our understanding of the
mechanism that accounts for the increasing incidence of
tendinopathy in aging populations.
The transforming growth factor (TGF)-β gene family
consists of at least five homologous genes that encode
proteins with a wide range of effects on the differ-
entiation and activity of many cell types [14]. Three
homodimeric isoforms (TGF-β1, -β2, and -β3) exist in
mammalian cells [15]. Studies reveal that TGF-β1 select-
ively stimulates the synthesis of connective tissue matrix
components both in vivo and in vitro, to control the for-
mation and degradation of connective tissues [16,17].
These effects might be augmented by reducing the syn-
thesis of proteinases (MMPs) [18-20], or by increasing
the expression of tissue inhibitors of MMP (TIMPs)
[20,21]. A study on the effects of aging on the synthesis
of rabbit fibroblast matrix showed that the fibroblasts
from aging rabbits produced significantly less collagen in
response to TGF-β1 than fibroblasts from young rabbits
did [22]. However, whether aging alters the secretion of
TGF-β in tenocytes has not yet been investigated.
The present study was undertaken to assess the effects
of aging on the expression of six mRNAs, the enzymatic
activities of MMP-2 and −9, and the secretion of TGF-
β1 from tenocytes.
Methods
All procedures were approved by the Institutional Ani-
mal Care and Use Committee of Chung Gung Memorial
Hospital, Taiwan.
Primary culture of rat Achilles tenocytes
Tenocytes were obtained from Sprague–Dawley rats, as
previously described [23]. The animals were divided
into 3 groups by age: young (2 months), middle-aged
(12 months), and near senescence (old, 24 months).
Samples from passages 2–4, which contained fibroblasts
with normal growth rates and shapes, were used. Similar
cell densities were used in each group at the start of the
experimental process, and all experiments were per-
formed at least in triplicate.3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide (MTT) assay
Tenocytes from all age groups were cultured, and cell
viability was measured by MTT assay both 24 h and
48 h after plating. After the addition of MTT (50 μg/ml),
the mixture was incubated at 37°C for 1 h. Next, the
MTT solution was discarded, and 1 ml of dimethyl sulf-
oxide (DMSO) was added to dissolve the formazan crys-
tals. The optical density of the aliquots was measured
at 570 nm OD570 nm using a spectrophotometer
(VICTOR™X3 Multilabel Plate Reader; PerkinElmer Inc,
Waltham, MA). Fold changes in the OD570 nm values
for the middle-aged and senescent tenocytes were calcu-
lated relative to the values for young tenocytes.
Isolation of RNA, reverse transcription, and quantitative
real-time polymerase chain reaction (PCR)
Tenocytes were lysed by using a guanidine isothiocyan-
ate buffer. Subsequently, total RNA was extracted with
phenol and chloroform/isoamyl alcohol (49:1) to remove
proteins and genomic DNA. One microgram of total
RNA was reverse-transcribed into complementary DNA
(cDNA) by incubating it with 200 units of reverse tran-
scriptase in 20 μl of reaction buffer containing 0.25 μg
of random primers and 0.8 mM dNTPs at 42°C for 1 h.
Quantitative real-time PCR was performed using an
SYBR Green and Mx3000P™ QPCR system (Stratagene,
La Jolla, CA). Aliquots (20 ng) of cDNA were used for
each quantitative PCR, and each reaction was run in
triplicate. The primers used are shown in Table 1. Rela-
tive gene expressions between experimental groups were
determined using MxPro software (Stratagene, La Jolla,
CA), and the mRNA that encodes glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was used as an
internal control.
Gelatin zymography
The presence of MMP-2 and MMP-9 in conditioned
medium was detected using gelatin zymography, which
was performed under non-reducing conditions in a 7.5%
SDS-polyacrylamide gel containing 2 mg/ml gelatin
(Mini-PROTEAN II system; Bio-Rad Laboratories Ltd,
Hempstead, UK). Gels were washed in 2.5% Triton X-
100 to remove SDS and allow renaturation of MMPs,
before they were transferred to a solution containing
50 mM Tris (pH 7.5), 5 mM CaCl2, and 1 mM ZnCl2,
followed by incubation at 37°C for 18 h. After staining
with Coomassie brilliant blue R250 (Bio-Rad Laborato-
ries, Hercules, CA), pro-MMPs and active MMPs were
observed as white lysis bands produced by gelatin de-
gradation. To quantify MMP-2 and MMP-9 activities,
densitometric analysis was performed using 1D Digital
Analysis Software (Kodak Digital Science; Eastman
Kodak Company, Rochester, NY). The values of MMP-2
Table 1 Primer sequences of target genes for
real-time PCR
Target genes Primer sequence
GAPDH 5’ AGTCTACTGGCGTCTTCA 3’ forward
5’ TTGTCATATTTCTCGTGGT 3’ reverse
COL1A1 5’ TACAGCACGCTTGTGGATG 3’ forward
5’ TTGGGATGGAGGGAGTTTA 3’ reverse
MMP-2 5’ GGAAGCATCAAATCGGACTG 3’ forward
5’ GGGCGGGAGAAAGTAGCA 3’ reverse
MMP-9 5’ CCCACTTACTTTGGAAACG 3’ forward
5’ GAAGATGAATGGAAATACGC 3’ reverse
TIMP-1 5’ GCCTCTGGCATCCTCTTG 3’ forward
5’ CTGCGGTTCTGGGACTTG 3’ reverse
TIMP-2 5’ CCAAAGCAGTGAGCGAGAA 3’ forward
5’ CCCAG GGCAC AATAA AGTC 3’ reverse
TGF-beta-1 5’ AGAGATTCAAGTCAAACTGTGGAG 3’ forward
5’ CCAAGGTAACGCCAGGAA 3’ reverse
Abbreviation: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; COL,
collagen; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of
metalloproteinase; TGF, transforming growth factor.
Figure 1 Results of the MTT assay of tenocytes from rats
from three age groups 24 h and 48 h after plating revealed
that the OD value of old tenocytes was significantly lower than
that of young tenocytes (Middle: middle aged; *p < 0.001,
** p < 0.001, n > 4).
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bers determined from the MTT assay.
Enzyme-linked immunosorbent assay (ELISA)
An ELISA was used to measure the concentration of
TGF-β1 in conditioned medium (culture supernatant) of
tendon cells. The medium was aspirated and transferred
to the wells of a 96-well ELISA plate that was pre-coated
with mouse anti-TGF-β1 antibody (360 μg/ml, 100 μl/
well; R&D Systems, Minneapolis, MN) overnight at
room temperature, according to the manufacturer’s pro-
cedures. The plate was then read using a microplate
reader set to measure absorbance at 450 nm
(VICTOR™X3 Multilabel Plate Reader; PerkinElmer Inc,
Waltham, MA). Recombinant TGF-β1 was serially
diluted from 0 to 2000 pg/ml, and the readings were
plotted to generate a standard curve. The amount of
TGF-β1 production was normalized relative to viable
cell numbers determined from the MTT assay after sub-
tracted the value of culture medium.
Statistical analysis
All data from the MTT assay and densitometric analysis
were expressed as mean ± SEM values. The analysis was
performed with SPSS 18.0 software for Windows (SPSS
Inc., Chicago, IL). Tenocytes among the three age
groups were compared using the nonparametric
Kruskal-Wallis test. The Mann–Whitney U-test was
used for comparisons between any two groups. P values
less than 0.05 were considered significant.Results
Effect of aging on tenocyte viability
Data from MTT assays revealed that aging lowered the
relative OD570 nm values of the aliquots (Figure 1). After
24 h, the respective OD570 nm values of the middle-aged
and old rats were 60.9% ± 11.4% and 43.0% ± 1.5% of
those of young rats. After 48 h, the respective OD570 nm
values of the middle-aged and old rats were 46.0% ±
1.8% and 39.8% ± 1.8% of those of young rats. This re-
sult indicated that the viable cell numbers of tenocytes
might decrease with age.
Effect of aging on mRNA expression
Quantitative real-time PCR was used to amplify and
simultaneously quantify our target mRNAs. Changes in
gene expressions were reported as multiples of increases
relative to young rats. Quantitative real-time PCR
revealed that levels of mRNAs that encode type-I
collagen and TGF-β1 were essentially indistinguishable
in tenocytes from young, middle-aged, and old rats
(Figure 2A and F). However, MMP-2 and −9 mRNA
expressions increased significantly with age (p < 0.001;
Figure 2B and C). Furthermore, as compared with young
rats, mRNAs that encode TIMP-1 and −2 were signifi-
cantly decreased in tenocytes from the old rats
(p < 0.001; Figure 2D and E).
Effect of aging on enzymatic activities of MMP-2 and −9
Gelatin zymography analysis of the activities of MMP-2
and MMP-9 revealed that MMP-2 made a greater
Figure 2 Quantitative real-time PCR revealed: (A) No significant differences among three age groups in the levels of the mRNA that
encodes type-I collagen; (B)(C) The level of the mRNA that encodes MMP-2 and MMP-9 increased with age (*p < 0.001, n = 3); (D)(E)
The level of the mRNA that encodes TIMP-1 and TIMP-2 decreased with age (*p < 0.001, n = 3); (F) No significant differences among
three age groups in the level of the mRNA that encodes TGF-β1.
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cells than MMP-9 did (Figure 3A). The activities of both
MMP-2 and MMP-9 were analyzed for the different age
groups by subtracting densitometric readings from the
background value and normalizing the data by using the
number of viable cells determined using the MTT assay.
Senescent tenocytes showed significantly higher gelati-
nase activities than young tenocytes (p < 0.05; Figure 3B
and C). This Finding indicates that both MMP-2 and
MMP-9 activities increase in an age-dependent manner.
Effect of aging on TGF-β1 secretion
The concentration of TGF-β1 in the conditioned
medium were 95.9 pg/ml, 95.8 ± 1.51 pg/ml, 98.9 ±
2.55 pg/ml, and 97.9 ± 1.59 pg/ml for culture medium
only and the young, middle-aged, and old tenocytes, re-
spectively. After subtracting the value of culture medium
and normalizing the data by using the number of viable
cells from MTT assay, the percentage of TGF-β1
production was indistinguishable in the conditioned
medium from the tenocytes collected from rats of different
ages (Figure 4).
Discussion
Tenocytes—the basic cellular component of tendons—pro-
duce collagens, other proteins, and matrix proteoglycans
[24]. Healing of injured tendons proceeds via three over-
lapping stages: inflammation, regeneration, and remodeling
[24,25]. Each stage prepares the healing process for thefollowing stage, so the impairment of one stage may nega-
tively impact the next one. Tenocyte proliferation is one of
the principal steps in the regeneration phase of tendon
healing. The results of this study indicate that tenocyte via-
bility (which may compose of cell proliferation ability and
metabolism) decreases with aging. This might partially ac-
count for the poor healing observed in aging tendons.
Similar results have been obtained in studies of wound
healing, where the proliferative capacity of fibroblast pro-
gressively decreases over time [26,27].
Matrix turnover, which involves both the synthesis and
degradation of matrix components, is important for the
maintenance and repair of tendons. Type-I collagen consti-
tutes around 60% of the dry mass of the tissue and ap-
proximately 95% of total collagen [6]. It appears that highly
stressed tendons show increased levels of collagen turnover
[28]. A study of pathologic human Achilles tendon showed
that levels of collagen type-I and -III mRNAs were signifi-
cantly higher in tendons with chronic pain or spontaneous
rupture than in normal tendons [10]. However, the present
study demonstrated that aging did not affect the level of
the mRNA that encodes type-I collagen. The expression of
type-I collagen mRNA is not expected to be a response of
aging-related collagen degradation.
The tendon matrix is constantly remodeled through-
out life. A relatively high level of matrix remodeling is
common in tendons such as the supraspinatus tendon,
and this process is linked to degenerative pathology [8].
It appears that MMPs play a key role in regulating
Figure 3 (A) Zymography of conditioned medium revealed the enzymatic activities of MMP-2 (lower band: 72 kDa) and MMP-9 (upper
band: 92 kDa). (B)(C) Densitometric analysis of MMP-2 and −9, with levels normalized to the number of viable cells determined using the MTT
assay, revealed markedly higher MMP-2 and −9 activity in senescent tenocytes than in the young tenocytes (*p < 0.001, n = 3).
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for the degradation of collagens and proteoglycans
[7,29]. The results of our present study reveal that the
activities of both MMP-2 and MMP-9 are higher in the
tendons of aging rats than in the tendons of young rats.
To the best of our knowledge, this is the first study toFigure 4 The percentage of TGF-β1 production in conditioned
medium from cultured tendon cells was not affected by the
age of the rats from which they were derived (n = 3).measure gelatinase activities in aging tenocytes. How-
ever, a similar age-dependent increase in MMP-2 or
MMP-9 activity was reported for samples of the skin,
heart, articular cartilage, and even plasma [30-33]. It is
reasonable to postulate that tendon degeneration may
result from the aging-induced over-expression of gelati-
nase activity. Regarding TIMPs, our data revealed that
both TIMP-1 and TIMP-2 mRNA expressions were
decreased in old tenocytes, suggesting the activities of
MMP-2 and −9 in old tenocytes, under less inhibitory
effect from TIMP-1 and −2, may further have a more
negative impact on the integrity of tendon matrix. These
findings provide a molecular mechanism that accounts
for the effect of aging on tendon healing. The over-
expression of gelatinase activities may impair the
turnover of matrix, which could lead to a qualitatively
different and mechanically less stable tendon that is
more susceptible to damage.
The transforming growth factor-β is active during al-
most all stages of tendon healing. During inflammation,
TGF-β has a variety of effects on the regulation of cellu-
lar migration and proliferation, as well as on the sti-
mulation of collagen production [15]. During tendon
synthesis, TGF-β1 significantly promoted the accumula-
tion of COL1A1 mRNA in cultured tendon fibroblasts
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expression at the transcriptional and post-transcriptional
levels by inducing an early increase in MMP-2 transcrip-
tion and an increase in the half-life of MMP-2 mRNA
[21]. It is also thought that TGF-β exerts a selective ef-
fect on ECM deposition by modulating the action of
other growth factors on metalloproteinase and TIMP ex-
pression [35]. Increased synthesis of TGF-β1 has also
been demonstrated for tendon fibroblasts subjected to
strain as well as in tendinosis fibroblast cultures [36,37].
However, our study demonstrated that although aging
could increase the activities of MMP-2 and −9, aging is
not significantly associated with TGF-β1 expression.
These observations suggest that TGF-β1 does not play a
major role in either the aging process related to tendinopa-
thy or the age-related regulation of gelatinase expression.
As for other cell culture models, there are several lim-
itations of the model used in the present study. For in-
stance, the behavior of explanted tendon cells is not
identical to the behavior of tendon cells in their natural
matrix environment in vivo [38,39]. Therefore, one
should always be cautious about translating culture data
directly to the in vivo situation. Further animal studies
are needed to assess the physiological relevance of our
findings. Aging may alter cell activity, but likely also
alters the biochemical environment [40]. It may be
speculated that using a reduced level of fetal bovine
serum (FBS) in culture medium might better simulate
the aging condition. Although the design of the present
study did not address the effects of different biochemical
environment, in previous investigations, it was clearly
shown that there was a decreased proliferation rate
when lower level of FBS was used. Besides, independent
of the levels of FBS in culture medium, there was a bet-
ter proliferation in cells from young donors than cells
from old donors at all times assessed [41]. Meanwhile,
immobilization has been demonstrated for an increase
of catabolic process of extracellular matrix by increasing
the expression of MMPs [42,43]. It is possible that differ-
ences in physical activity between the age groups might
partly account for the findings in this study. Further
study may be performed to compare the MMPs expres-
sion between the effects of inactivity and aging.
Conclusion
This study demonstrated an age-related increase in the
level of gelatinase (MMP-2 and MMP-9) activities and
decrease in the mRNA expression of TIMP-1 and
TIMP-2 in tenocytes, without any effect of age on the
levels of mRNA that encodes type-I collagen or TGF-β1
activity. These results imply that aging might exert a
negative effect on tendon structure or its healing pro-
cess by a mechanism that involves increased MMP-2
and MMP-9 activities, and decreased proliferation oftenocytes. Furthermore, the common growth regulator
TGF-β does not appear to affect the aging process in
tendons.
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